市場調査レポート
商品コード
1297792
皮膚炎用皮膚化粧品の世界市場-2023年~2030年Global Dermatitis Dermocosmetic Products Market - 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
皮膚炎用皮膚化粧品の世界市場-2023年~2030年 |
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
|
皮膚炎用皮膚化粧品の世界市場は、2022年に29億米ドルに達し、2030年には66億米ドルとなる見通しで、有利な成長が予測されています。皮膚炎用皮膚化粧品の世界市場は、予測期間中(2023-2030年)にCAGR 11.1%を示すと予測されます。天然素材やオーガニック製品に対する需要の高まり、成分配合の進歩、デジタルプラットフォームとeコマースの統合は、皮膚炎用皮膚化粧品市場の最近の動向です。
世界の皮膚炎用皮膚化粧品市場は近年継続的に拡大しています。皮膚炎は炎症や炎症を特徴とする一般的な皮膚疾患であり、世界人口の大きな割合を占めています。皮膚炎に特化した皮膚化粧品は、敏感で炎症を起こしている皮膚に緩和、鎮静、保護を提供します。
皮膚炎用皮膚化粧品の世界市場規模は、クレンジングや石鹸、保湿剤/ローション、フェイスクリーム、ローション、クレンジングオイル、美容液、その他皮膚炎用皮膚化粧品市場シェアを伸ばしている製品タイプを含む構成要素で構成されています。皮膚炎用皮膚化粧品の世界市場は、皮膚炎の有病率の増加、消費者のスキンケアソリューションに対する意識と需要の高まり、皮膚科学の研究と技術の進歩、老人人口の増加などの要因により拡大しています。
天然製品に対する認識と志向の高まりが、皮膚炎用皮膚化粧品市場の成長を促進すると予測されます。消費者は、スキンケア製品に含まれる合成物質や化学物質の潜在的な危険性を認識するようになっています。その結果、肌にやさしく潜在的な刺激物質が少ないと考えられる天然素材やオーガニックの代替品を求める声が高まっています。
例えば、アトピー性皮膚炎は、ビタミンFやオメガ6を多く含む月見草オイルのような栄養補助食品や、ゴボウやカシスのようなハーブ療法を用いることで効率的にコントロールすることができます。
さらに、皮膚の保湿と洗浄も外的ケアには欠かせない要素です。アロエベラや、植物油(スイートアーモンド、ホホバ)のような保湿、治癒、軟化の特徴を持つ自然な選択肢が人気を集めています。カプリル酸のような特定のトリグリセリドの助けを借りて、ヤギのミルクの石鹸は、清潔にして皮膚のバランスを保つことができると患者の間で評判になっています。ヤギのミルク石鹸は、肌を清潔にし、肌のバランスを保つことができると患者の間で評判になっています。
皮膚炎用皮膚化粧品市場は、製品組成の改良によって完全に変貌を遂げ、皮膚炎症状を治療する独創的な方法を提供するようになっています。メーカー各社は、科学的研究に基づき、皮膚の炎症や炎症を抑える効果で有名な化学物質を配合しています。
例えば、多くの皮膚化粧品には、セラミドのような科学的根拠のある成分が配合されています。セラミドは脂質(脂肪分子)であり、皮膚バリアの健全な機能を助け、皮膚の水分維持を助ける。これらの処方は、水分の損失を食い止め、刺激から肌を保護することで、長期的な緩和を提供します。
皮膚化粧品、特にアトピー性皮膚炎用の化粧品は、皮膚アレルギーや過敏症があると効果が低下する可能性があります。アレルゲンがマイナスの免疫学的反応を引き起こすと、アレルギー反応が生じる。スキンケア製品に含まれる化学物質、香料、防腐剤、着色料などがアレルゲンとなることが多いです。炎症、発疹、かゆみ、発赤、さらにはじんましんは、アレルギー反応の症状の一部です。
さらに、刺激性接触皮膚炎と呼ばれる非アレルギー性反応も、特定の化学物質や刺激の強い物質、その他の刺激物に直接触れることで生じることがあります。かゆみ、チクチク感、ほてり、皮膚の赤みなどは、この病気が引き起こす可能性のある症状のほんの一部です。
COVID-19のパンデミックと世界各国でのロックダウンにより、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局(FDA)は、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準(GCP)を遵守し、試験の完全性に対するリスクを最小限に抑えるための一般的な配慮を含むガイドラインを発表しました。
ロシア・ウクライナ紛争は、皮膚炎用皮膚化粧品の世界市場を不安定化させる可能性があります。サプライチェーンの中断、市場の不安定性、経済的影響はすべて、品不足、投資の減少、消費者需要の低下につながる可能性があります。ヘルスケア目標の変化や地域的な市場変動も影響を及ぼす可能性があります。影響の深刻さは、紛争の長さと深刻さ、そして緩和策の効率によって決まる。このような困難な状況の中、この業界で事業を行う組織には、継続的な監視と適応可能な方法が必要となります。
The Global Dermatitis Dermocosmetic Products Market reached US$ 2.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.6 billion by 2030. The global dermatitis dermocosmetic products market is expected to exhibit a CAGR 11.1% during the forecast period (2023-2030). The growing demand for natural and organic products, advancements in ingredient formulation, and integration of digital platforms and e-commerce are recent trends for dermatitis dermocosmetic products market.
The global dermatitis dermocosmetic products market has been expanding continuously in recent years. Dermatitis, a common skin condition characterized by inflammation and irritation, affects a large percentage of the global population. Dermatitis-specific dermocosmetic products provide relief, calming benefits, and protection for sensitive and inflamed skin.
The global dermatitis dermocosmetic products market scope comprises components encompassing product type such as cleansers and soaps, moisturizers/lotions, face cream, lotion, cleansing oil, serum, and other which has increased usage of dermatitis dermocosmetic products market share. The global market for dermatitis dermocosmetic products is expanding as a result of factors including growing prevalence of dermatitis, rising consumer awareness and demand for skincare solutions, advancements in dermatology research and technology, and growing geriatric population.
The growing awareness and inclination for natural products are projected to propel the dermatitis dermocosmetic products market forwards. Consumers are becoming more aware of the potential hazards of synthetic substances and chemicals present in skincare products. As a result, there is an increasing desire for natural and organic alternatives that are thought to be softer on the skin and contain fewer potential irritants.
For instance, atopic dermatitis can be efficiently controlled by using dietary supplements like evening primrose oil, which is high in vitamin F or omega-6, and herbal treatments like burdock and blackcurrant.
Moreover, moisturizing and cleaning the skin are essential components of external care. Aloe vera and other natural choices with moisturizing, healing, and softening characteristics, like vegetable oils (sweet almond, jojoba), are becoming more popular. With the help of certain triglycerides like caprylic acid, goat's milk soap has a reputation among patients for being able to cleanse and preserve skin balance. There driving the market growth over the foreseeable future.
The market for dermatitis dermocosmetic products has been completely transformed by improvements in product composition, which now offers creative ways to treat dermatitis symptoms. Manufacturers are integrating chemicals renowned for their effectiveness in reducing skin inflammation and irritation based on scientific studies.
For instance, many dermocosmetic solutions now include components with a strong scientific foundation, such as ceramides, which are lipids (fat molecules) that aid in the healthy functioning of the skin barrier and help the skin maintain moisture. These formulas work to stop moisture loss and shield the skin from irritants in order to offer long-lasting relief.
Dermocosmetic products, particularly those made for atopic dermatitis, might be less effective if an individual has skin allergies or sensitivities. When an allergen triggers a negative immunological response, an allergic response results. Chemicals, scents, preservatives, and colors are frequently found to be allergens in skincare products. Inflammation, rashes, itching, redness, and even hives are some of the symptoms of allergic responses.
Furthermore, a non-allergic reaction called irritating contact dermatitis can also result from coming into direct contact with certain chemicals, harsh substances, or other irritants. Itching, stinging, burning, and skin redness are just a few symptoms that this illness may produce.
The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.
The Russia-Ukraine conflict has the potential to destabilize the global market for dermatitis dermocosmetic products. Supply chain interruptions, market volatility, and economic consequences can all lead to shortages, reduced investment, and lower consumer demand. Shifting healthcare goals and regional market variations may also have an impact. The severity of the consequences will be determined by the length and severity of the dispute, as well as the efficiency of mitigating measures. During these difficult circumstances, organizations operating in this industry will require continuous monitoring and adaptable methods.
The global dermatitis dermocosmetic products market is segmented based on product type, application, distribution channel and region.
The atopic dermatitis category is expected to dominate the market for dermatitis dermocosmetic products. Eczema, commonly referred to as atopic dermatitis, is a persistent inflammatory skin disorder that is extremely common around the world. The care of symptoms is of utmost importance to people affected because it is characterized by dry, itchy, and irritated skin. Moisturizers, lotions, creams, and cleansers are examples of products that help restore the skin barrier, soothe irritation, reduce inflammation, and relieve itching.
There is a significant market for dermatitis dermocosmetic products designed specifically to address the symptoms and offer relief due to the high prevalence of atopic dermatitis and the impact it has on people's quality of life. For instance, according to the International Eczema Council report of 2022, atopic dermatitis was reported to affect roughly 223 million people, with approximately 43 million of them falling into the age category of 1-4 years. This underlines the condition's alarmingly high incidence among young children.
The United States' growing aging population is likely to dominate the global dermatitis dermocosmetic products market. According to United States Census Bureau data for 2023, the American Community Survey predicted that there were 55,892,014 people aged 65 and up in the United States, accounting for approximately 16.8% of the total population of 331,893,745.
Dermatitis is more common in the elderly due to changes in skin physiology and decreased skin barrier function. This demographic frequently seeks effective remedies for dermatitis symptoms and overall skin health. As a result, the demand for dermatitis dermocosmetic solutions tailored exclusively for the needs of the aged population is predicted to rise. As a result of the aforementioned factors, the North American region is expected to hold the biggest market share throughout the projection period.
The major global players in the dermatitis dermocosmetic products market include: Codex Labs Corp, Johnson & Johnson, L'Oreal S.A., Procter & Gamble Co., Galderma SA, Pierre-Fabre SA, GALDERMA LABORATORIES, L.P., Shiseido Company, Beiersdorf, and Bausch Health Companies Inc., among others.
The global dermatitis dermocosmetic products market report would provide approximately 53 tables, 54 figures and 195 Pages.
LIST NOT EXHAUSTIVE